마니디핀

Manidipine
마니디핀
Manidipine.svg
임상자료
상명다임퍼 등
AHFS/Drugs.com국제 마약 이름
경로:
행정
구강
ATC 코드
법적현황
법적현황
  • 일반: ℞ (처방에만 해당)
식별자
  • (±-)-2-[4-(디페닐메틸)피페라진-1-yl]에틸메틸 2,6-디메틸-4-(3-니트로페닐)-1,4-디하이드롭디리딘-3,5-디카르복실산염
CAS 번호
펍켐 CID
켐스파이더
유니
CompTox 대시보드 (EPA)
화학 및 물리적 데이터
공식C35H38N4O6
어금질량610.711 g·190−1
3D 모델(JSmol)
  • [O-][N+] ]c1cccc(c1)C5C(/C(=O)OC)=C(\N\C(=C5\C(=O)OCCN4CCN(C(c2ccc2)c3ccc3)CC4)C)C
  • InChI=1S/C35H38N4O6/c1-24-30(34(40)44-3)32(28-15-10-16-29(23-28)39(42)43)31(25(2)36-24)35(41)45-22-21-37-17-19-38(20-18-37)33(26-11-6-4-7-12-26)27-13-8-5-9-14-27/h4-16,23,32-33,36H,17-22H2,1-3H3

마니디핀(Manidipine)은 칼슘 채널 차단제(dihydropyridine type)로, 임상적으로 고혈압 치료제로 사용된다.[1][2][3][4][5]

1982년에 특허를 받았고 1990년에 의료용으로 승인되었다.[6]

참조

  1. ^ Cheer SM, McClellan K (2001). "Manidipine: a review of its use in hypertension". Drugs. 61 (12): 1777–99. doi:10.2165/00003495-200161120-00010. PMID 11693466. Archived from the original on 2013-01-17. Retrieved 2009-06-20.
  2. ^ McKeage K, Scott LJ (2004). "Manidipine: a review of its use in the management of hypertension". Drugs. 64 (17): 1923–40. doi:10.2165/00003495-200464170-00011. PMID 15329044. Archived from the original on 2013-01-16. Retrieved 2009-06-20.
  3. ^ Roca-Cusachs A, Triposkiadis F (2005). "Antihypertensive effect of manidipine". Drugs. 65 Suppl 2: 11–9. doi:10.2165/00003495-200565002-00003. PMID 16398058. S2CID 25854593. Archived from the original on 2013-01-16. Retrieved 2009-06-20.
  4. ^ Otero ML (2007). "Manidipine-delapril combination in the management of hypertension". Vascular Health and Risk Management. 3 (3): 255–63. PMC 2293964. PMID 17703633.
  5. ^ Mizuno K, Haga H, Takahashi M, Fukuchi S (August 1992). "Evaluation of manidipine hydrochloride, a new calcium antagonist, in the treatment of hypertensive patients with renal disorders". Current Therapeutic Research. 52 (2): 248–253. doi:10.1016/S0011-393X(05)80475-8.
  6. ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 465. ISBN 9783527607495.